These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31606562)

  • 1. Advanced analytical methodologies in Alzheimer's disease drug discovery.
    De Simone A; Naldi M; Tedesco D; Bartolini M; Davani L; Andrisano V
    J Pharm Biomed Anal; 2020 Jan; 178():112899. PubMed ID: 31606562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer's Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data.
    Kocis P; Tolar M; Yu J; Sinko W; Ray S; Blennow K; Fillit H; Hey JA
    CNS Drugs; 2017 Jun; 31(6):495-509. PubMed ID: 28435985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening strategies to identify HSP70 modulators to treat Alzheimer's disease.
    Repalli J; Meruelo D
    Drug Des Devel Ther; 2015; 9():321-31. PubMed ID: 25609918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and Future of Alzheimer's Therapy with the Best Approach.
    Singh H; Chawla V; Bala R; Dureja H
    CNS Neurol Disord Drug Targets; 2020; 19(9):691-697. PubMed ID: 32351189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and Elucidation of Selected Natural Compounds for Anti- Alzheimer's Potential Targeting BACE-1 Enzyme: A Case Computational Study.
    Ahmad SS; Akhtar S; Danish Rizvi SM; Kamal MA; Sayeed U; Khan MKA; Siddiqui MH; Arif JM
    Curr Comput Aided Drug Des; 2017 Nov; 13(4):311-318. PubMed ID: 28413992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in the development of beta-secretase inhibitors for Alzheimer's disease.
    Albert JS
    Prog Med Chem; 2009; 48():133-61. PubMed ID: 21544959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-secretase as a target for Alzheimer's disease drug discovery: an overview of in vitro methods for characterization of inhibitors.
    Mancini F; De Simone A; Andrisano V
    Anal Bioanal Chem; 2011 Jun; 400(7):1979-96. PubMed ID: 21503735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-target-directed therapeutic potential of 7-methoxytacrine-adamantylamine heterodimers in the Alzheimer's disease treatment.
    Gazova Z; Soukup O; Sepsova V; Siposova K; Drtinova L; Jost P; Spilovska K; Korabecny J; Nepovimova E; Fedunova D; Horak M; Kaniakova M; Wang ZJ; Hamouda AK; Kuca K
    Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):607-619. PubMed ID: 27865910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aβ regulation-based multitarget strategy for drug discovery against Alzheimer's disease.
    Guo X; Jiang W; Li C; Zhu Z; Shen X
    Rev Neurosci; 2015; 26(1):13-30. PubMed ID: 25720054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural Products in Alzheimer's Disease Therapy: Would Old Therapeutic Approaches Fix the Broken Promise of Modern Medicines?
    Habtemariam S
    Molecules; 2019 Apr; 24(8):. PubMed ID: 30999702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A microfluidics-based mobility shift assay to identify new inhibitors of β-secretase for Alzheimer's disease.
    Liu R; Liu YC; Meng J; Zhu H; Zhang X
    Anal Bioanal Chem; 2017 Nov; 409(28):6635-6642. PubMed ID: 28889204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of BACE for treating Alzheimer's disease: a fragment-based drug discovery story.
    Stamford A; Strickland C
    Curr Opin Chem Biol; 2013 Jun; 17(3):320-8. PubMed ID: 23683349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of Biophysics in High-Throughput Screening Hit Validation.
    Genick CC; Barlier D; Monna D; Brunner R; Bé C; Scheufler C; Ottl J
    J Biomol Screen; 2014 Jun; 19(5):707-14. PubMed ID: 24695619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-target-directed ligands in Alzheimer's disease treatment.
    Bajda M; Guzior N; Ignasik M; Malawska B
    Curr Med Chem; 2011; 18(32):4949-75. PubMed ID: 22050745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying natural compounds as multi-target-directed ligands against Alzheimer's disease: an in silico approach.
    Ambure P; Bhat J; Puzyn T; Roy K
    J Biomol Struct Dyn; 2019 Mar; 37(5):1282-1306. PubMed ID: 29578387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiwell fluorometric and colorimetric microassays for the evaluation of beta-secretase (BACE-1) inhibitors.
    Mancini F; Naldi M; Cavrini V; Andrisano V
    Anal Bioanal Chem; 2007 Jul; 388(5-6):1175-83. PubMed ID: 17541560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in drug development for Alzheimer's disease: An overview in relation to mitochondrial energy metabolism.
    Hroudová J; Singh N; Fišar Z; Ghosh KK
    Eur J Med Chem; 2016 Oct; 121():774-784. PubMed ID: 27094132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol for fast screening of multi-target drug candidates: Application to Alzheimer's disease.
    Thai NQ; Nguyen HL; Linh HQ; Li MS
    J Mol Graph Model; 2017 Oct; 77():121-129. PubMed ID: 28850894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the identification of β-secretase inhibitors.
    Hamada Y; Kiso Y
    Expert Opin Drug Discov; 2013 Jun; 8(6):709-31. PubMed ID: 23565721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a BACE1 Binding Peptide Candidate for the Prevention of Amyloid Beta in Alzheimer's Disease.
    Read J; Suphioglu C
    Cell Physiol Biochem; 2019; 53(2):413-428. PubMed ID: 31415717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.